| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.63M | 36.62M | 8.24M | 25.23M | 24.42M | 21.66M |
| Gross Profit | 33.51M | 36.62M | 8.24M | -54.65M | 19.42M | 15.60M |
| EBITDA | 13.66M | 0.00 | 19.21M | -76.67M | -18.14M | 13.32M |
| Net Income | 29.64M | 31.06M | 3.02M | -54.72M | 89.37M | 4.54M |
Balance Sheet | ||||||
| Total Assets | 501.97M | 496.87M | 478.03M | 490.26M | 544.96M | 460.10M |
| Cash, Cash Equivalents and Short-Term Investments | 6.80M | 3.72M | 6.00M | 8.42M | 11.60M | 12.18M |
| Total Debt | 0.00 | 0.00 | 177.43M | 178.60M | 163.78M | 155.36M |
| Total Liabilities | 199.08M | 195.49M | 190.68M | 189.57M | 172.77M | 163.25M |
| Stockholders Equity | 302.90M | 301.38M | 287.35M | 300.69M | 372.18M | 296.84M |
Cash Flow | ||||||
| Free Cash Flow | 18.44M | 18.58M | 23.88M | 17.68M | 19.06M | 8.66M |
| Operating Cash Flow | 18.44M | 18.58M | 23.88M | 17.68M | 19.06M | 8.66M |
| Investing Cash Flow | -1.33M | -1.93M | -2.00M | -14.25M | -9.96M | -36.53M |
| Financing Cash Flow | -16.29M | -18.94M | -24.29M | -6.62M | -9.68M | 7.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £60.38M | 4.85 | 10.22% | 8.23% | 8.48% | 207.85% | |
72 Outperform | £420.67M | 3.34 | 11.57% | 7.17% | 1.60% | 211.81% | |
71 Outperform | £164.07M | 9.16 | 7.33% | 7.43% | -10.95% | -30.09% | |
67 Neutral | £241.38M | 5.97 | 9.81% | 6.64% | ― | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | £409.59M | 6.81 | 7.51% | 5.15% | -3.98% | 412.08% | |
51 Neutral | £51.93M | -11.90 | -0.96% | 5.02% | -9.28% | ― |